HB1830--ALTERNATIVETHERAPIES
SPONSOR: McMullen
Asspecifiedinthisbill,anypersonwhoacquires,uses,produces,
possesses,transfers,oradministerspsilocybinfortheperson's
owntherapeuticusewillnotbeinviolationofstateorlocallaw
andwillnotbesubjecttoacivilfine,penalty,orsanctionso
longasthepersonmeetsthefollowingconditions:
(1)Is21yearsofageorolder;
(2)Suffersfromposttraumaticstressdisorder,majordepressive
disorder,orasubstanceusedisorderorrequiresend-of-lifecare;
(3)Hasenrolledinaclinicaltrialtostudytheuseof
psilocybintotreatposttraumaticstressdisorder,majordepressive
disorder,orsubstanceusedisordersorforend-of-lifecareor
soughttoenrollinaclinicaltrialbutwasdeclinedduetolack
ofspaceorlackofexistingclinicaltrialsforwhichtheperson
waseligible;
(4)InformstheDepartmentofHealthandSeniorServicesthatthe
personplanstoacquire,use,produce,possess,transfer,or
administerpsilocybininaccordancewiththissection;
(5)ProvidestheDepartmentwithdocumentsoutlinedinthebill.
TheDepartmentmustmaintaintheconfidentiality ofanypersonally
identifiableprotectedinformationcollectedfromanypersonswho
provideinformationtotheDepartment;
(6)EnsuresthatalaboratorylicensedbytheStatetotest
controlledsubstancesteststhepsilocybinthepersonintendsto
ingest.AnylaboratorylicensedbytheStatetotestcontrolled
substancesorcannabisthattestspsilocybinshallnotbein
violationofstateorlocallawandshallnotbesubjecttoacivil
fine,penalty,orsanction;and
(7)Limitstheuseofpsilocybintonomorethan150milligramsof
psilocybinanalyte(4-phosphoryloxy-N,Ndimethyltryptamine) during
any12monthperiod.
TheDepartmentmustprepareandsubmittotheGovernor,Lieutenant
Governor,andtheGeneralAssemblyannualreportsonany
informationcollectedbytheDepartmentontheimplementation and
outcomesoftheuseofpsilocybin.
Thisbillspecifiesthat,aphysicianwillnotbesubjectto
criminalorcivilliabilityorsanctionunderthelawsofthis Stateforprovidingdocumentationthatapersonsuffersfrom
posttraumaticstressdisorder,majordepressivedisorder,ora
substanceusedisorderorrequiresend-of-lifecare,andnoState
agencyorregulatoryboardshallrevoke,failtorenew,ortakeany
otheractionagainstaphysician'slicenseissuedunderChapter
334,RSMobasedsolelyonthephysician'sprovisionof
documentationthatapersonsuffersfromposttraumaticstress
disorder,majordepressivedisorder,orasubstanceusedisorderor
requiresend-of-lifecare.
ThisbillalsorequirestheDepartment,incollaborationwitha
hospitaloperatedbytheaninstitutionofhighereducationinthis
stateorcontractresearchorganizationsconductingtrialsapproved
bytheUnitedStatesFoodandDrugAdministration inMissouri,to
conductastudyontheefficacyofusingalternativemedicinesand
therapies,including,butnotlimitedto,theuseofpsilocybinfor
thetreatmentofpatientssufferingfrompost-traumaticstress
disorder,majordepressivedisorder,substanceusedisorders,or
whorequireendof-lifecare.
Thebillspecifiesthatsuchstudyshallincludeaclinicaltrial
ofpsilocybin,aswellasaliteraturereviewandthesubmissionof
variousreports. Nopersonparticipatingintheclinicaltrial
shallbesubjectedtocriminalorcivilliabilityorsanctionfor
theparticipationintheclinicaltrial,exceptincasesofgross
negligenceorwillfulmisconduct.
TheDepartmentofHealthandSeniorServicesshallprepareand
submittotheGovernor,LieutenantGovernorandtheGeneral
Assembly:
(1)Quarterlyreportsontheprogressofthestudy;and
(2)Awrittenreport,submittedoneyearfollowingthe
commencementofthestudy,whichshall:
(a)Containtheresultsofthestudyandanyrecommendations for
legislativeorregulatoryaction;and
(b)Highlightthoseclinicalpracticesthatappeartobemost
successfulaswellasanysafetyorhealthconcerns.
TheDepartmentmustmaintaintheconfidentiality ofanypersonally
identifiableprotectedinformationcollectedduringtheclinical
trial.Aphysicianwillnotbesubjecttocriminalorcivil
liabilityorsanctionunderthelawsofthisstateforreferringa
patienttotheclinicaltrialunderthissection,andnostate
agencyorregulatoryboardshallrevoke,failtorenew,ortakeany
otheractionagainstaphysician'slicensebasedsolelyonthe physician'sreferralofapatienttotheclinicaltrialunderthis
section.
ThisbillissimilartoHB1154(2023).